Literature DB >> 7936647

The RI alpha subunit of protein kinase A controls serum dependency and entry into cell cycle of human mammary epithelial cells.

G Tortora1, S Pepe, C Bianco, G Baldassarre, A Budillon, T Clair, Y S Cho-Chung, A R Bianco, F Ciardiello.   

Abstract

MCF-10A, a nontransformed mammary epithelial cell line, requires a mixture of hormones and growth factors for optimal cell proliferation. In this report we show that when MCF-10A cells are cultured in serum free medium they become quiescent and accumulate in G0/G1 phases of the cell cycle. Following addition of complete medium to quiescent cells, MCF-10A cells enter into the S phase within 15-18 h and resume the cell cycle distribution of proliferating cells within 24 h. Measurement of RI alpha subunit of the cAMP-dependent protein kinase (PKA) shows a 10- to 15-fold increase in protein levels at 6 h following complete medium addition, thus preceding cell entry into the S phase. Retroviral vector-mediated overexpression of RI alpha, but not of RII beta or C alpha subunits of PKA, enables MCF-10A cells to grow in serum-free medium. In addition, RI alpha downregulation by specific antisense oligodeoxynucleotide treatment or following infection with a retroviral vector containing the RI alpha cDNA in antisense orientation determines growth arrest of proliferating MCF-10A cells and is able to partially block S phase entry of quiescent MCF-10A cells following complete medium addition. These results suggest that RI alpha/PKAI is involved in the control of cell cycle progression of mammary epithelial cells at a G1 to S transition border, and that its overexpression is able to overcome serum and growth factors requirement for cell proliferation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7936647

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  11 in total

1.  Over-expressed human TREK-1 inhibits CHO cell proliferation via inhibiting PKA and p38 MAPK pathways and subsequently inducing G1 arrest.

Authors:  Man Zhang; Hua-Jing Yin; Wei-Ping Wang; Jiang Li; Xiao-Liang Wang
Journal:  Acta Pharmacol Sin       Date:  2016-07-11       Impact factor: 6.150

2.  Activation of cyclic AMP-dependent kinase is required but may not be sufficient to mimic cyclic AMP-dependent DNA synthesis and thyroglobulin expression in dog thyroid cells.

Authors:  S Dremier; V Pohl; C Poteet-Smith; P P Roger; J Corbin; S O Doskeland; J E Dumont; C Maenhaut
Journal:  Mol Cell Biol       Date:  1997-11       Impact factor: 4.272

3.  Interaction of the regulatory subunit of the cAMP-dependent protein kinase with PATZ1 (ZNF278).

Authors:  Weng-Lang Yang; Roald Ravatn; Kazuya Kudoh; Leah Alabanza; Khew-Voon Chin
Journal:  Biochem Biophys Res Commun       Date:  2009-12-22       Impact factor: 3.575

4.  Growth arrest and induction of apoptosis in breast cancer cells by antisense depletion of protein kinase A-RI alpha subunit: p53-independent mechanism of action.

Authors:  R K Srivastava; A R Srivastava; P Seth; S Agrawal; Y S Cho-Chung
Journal:  Mol Cell Biochem       Date:  1999-05       Impact factor: 3.396

5.  Ala99ser mutation in RI alpha regulatory subunit of protein kinase A causes reduced kinase activation by cAMP and arrest of hormone-dependent breast cancer cell growth.

Authors:  G R Lee; S N Kim; K Noguchi; S D Park; S H Hong; Y S Cho-Chung
Journal:  Mol Cell Biochem       Date:  1999-05       Impact factor: 3.396

6.  Progressive increase of glucose transporter-3 (GLUT-3) expression in estrogen-induced breast carcinogenesis.

Authors:  M A Kocdor; H Kocdor; J S Pereira; J E Vanegas; I H Russo; J Russo
Journal:  Clin Transl Oncol       Date:  2012-10-02       Impact factor: 3.405

7.  Synergistic inhibition of human cancer cell growth by cytotoxic drugs and mixed backbone antisense oligonucleotide targeting protein kinase A.

Authors:  G Tortora; R Caputo; V Damiano; R Bianco; S Pepe; A R Bianco; Z Jiang; S Agrawal; F Ciardiello
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-11       Impact factor: 11.205

8.  Protein kinase A RI-alpha predicts for prostate cancer outcome: analysis of radiation therapy oncology group trial 86-10.

Authors:  Li-Yan Khor; Kyounghwa Bae; Tahseen Al-Saleem; Elizabeth H Hammond; David J Grignon; William T Sause; Miljenko V Pilepich; Paul P Okunieff; Howard M Sandler; Alan Pollack
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-05-01       Impact factor: 7.038

9.  Protein kinase A activation confers resistance to trastuzumab in human breast cancer cell lines.

Authors:  Long Gu; Sean K Lau; Sofia Loera; George Somlo; Susan E Kane
Journal:  Clin Cancer Res       Date:  2009-11-17       Impact factor: 12.531

10.  Isoform-specific targeting of PKA to multivesicular bodies.

Authors:  Michele E Day; Guido M Gaietta; Mira Sastri; Antonius Koller; Mason R Mackey; John D Scott; Guy A Perkins; Mark H Ellisman; Susan S Taylor
Journal:  J Cell Biol       Date:  2011-04-18       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.